CityClinic Przychodnia Lekarsko-Psychologiczna

Wroclaw 50-566

1 studies enrolling now · 6 studies all time

What they study most

Alopecia, Areata Alopecia, Atopic Dermatitis, Hair Diseases, Hypotrichosis, Pathological Conditions, Anatomical, Psoriasis, Skin Diseases

Studies at this site

• A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata — Recruiting now
• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS) — Completed
• Study to Assess the Efficacy and Safety of Orismilast in Psoriasis — Completed
• Study to Assess the Safety and Efficacy of Lebrikizumab (LY3650150) in Adolescent Participants With Moderate-to-Severe Atopic Dermatitis — Completed
• Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1) — Completed